Biotech & Life Sciences

Three of the world's largest drugmakers have pledged a combined $18.5 billion to China in under three months.

The U.S.

Doctronic, the AI healthcare startup that bills itself as the "world's most popular AI doctor," isn't just raising money.

Tang Capital's founder installed himself and two longtime lieutenants atop the lupus nephritis drugmaker, ousting four executives in a move disclosed in an SEC filing Monday.

Sanofi Bets $180M on a San Mateo Startup's Plan to Reset the Immune System Sanofi has licensed worldwide exclusive rights to KT501, a first-in-class trispecific T-cell engager developed by Kali Therapeutics, a small San Mateo startup that dosed its [first patient](https://www.prnewswire.com/news...

Insmed's Arikayce Clears Phase 3 in First-Line MAC Lung Disease, Setting Up a Second Blockbuster Insmed announced [positive topline results](https://investor.insmed.com/2026-03-23-Insmed-Announces-Positive-Topline-Results-from-Phase-3b-ENCORE-Study-of-ARIKAYCE-R-Amikacin-Liposome-Inhalation-Susp...

The First Lyme Vaccine in 24 Years Works.

Two Injections a Year: Apogee's Eczema Drug Posts Durability Data That Could Reshape the Dupixent Era Apogee Therapeutics released 52-week maintenance data for zumilokibart, its anti-IL-13 antibody for moderate-to-severe atopic dermatitis.

The pharma giant is acquiring Synnovation's mutant-selective PI3Kα inhibitor SNV4818, a bet that precision targeting can solve the tolerability problems that have haunted its first-generation Piqray.

The first DNA nanorobot that can be programmed like a computer chip has emerged from a collaboration between two labs on different continents — and it arrives at a moment when the field desperately needs to answer a question it has been dodging for nearly a decade: when does any of this become re...

Researchers tracked antibiotics from the Piracicaba River into fish sold at local markets, and found that an aquatic plant's cleanup efforts come with a biological catch.